Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

NCT00203931 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
55
Enrollment
OTHER
Sponsor class

Stopped Slow accrual and evidence from other studies showing benefit of early initiation of pemetrexed after first-line therapy

Conditions

Interventions

Sponsor

University of Chicago

Collaborators